| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3B | $14.1B | $14.2B | $15.8B | $14.8B | $10.2B | $2.6B | $2.6B |
| Cost of Revenue | $11.6B | $11.4B | $11.6B | $12.7B | $12.0B | $8.3B | $2.0B | $2.0B |
| Gross Profit | $2.7B | $2.6B | $2.6B | $3.1B | $2.9B | $1.9B | $0.5B | $0.5B |
| R&D Expense | $0.7B | $0.7B | $0.7B | $0.8B | $0.7B | $0.5B | $0.4B | $0.4B |
| SG&A Expense | $1.3B | $1.4B | $1.3B | $1.6B | $1.5B | $1.0B | $0.2B | $0.2B |
| Operating Income | $0.5B | $0.5B | $1.2B | $1.4B | $1.2B | $0.6B | $0.5B | $0.3B |
| Net Income | $0.3B | $0.3B | $0.2B | $0.9B | $0.5B | $0.5B | $0.2B | $0.2B |
| EPS (Basic) | $1.29 | $1.51 | $2.68 | $4.01 | $2.25 | $2.35 | $1.07 | $1.11 |
| EPS (Diluted) | $1.28 | $1.50 | $2.67 | $3.99 | $2.24 | $2.34 | $1.06 | $1.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.8B | $14.0B | $14.5B | $17.0B | $16.6B | $16.0B | $9.7B | $10.1B |
| Current Assets | $6.8B | $6.5B | $6.2B | $6.6B | $6.6B | $6.2B | $3.8B | $3.8B |
| Cash & Equivalents | — | — | — | — | $1.8B | $1.6B | $0.8B | $0.7B |
| Total Liabilities | $8.2B | $8.3B | $8.4B | $9.5B | $9.3B | — | — | — |
| Current Liabilities | $3.3B | $3.6B | $3.8B | $4.2B | $3.8B | $3.8B | $2.3B | $2.4B |
| Stockholders' Equity | $5.4B | $5.5B | $5.8B | $7.2B | $6.9B | $6.4B | $4.7B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | $1.6B | $1.3B | $1.2B | $1.0B | $1.1B |
| Investing Cash Flow | — | — | — | $-1.4B | $-1.4B | $-0.9B | $-0.5B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | $-0.6B | $0.3B | $0.4B | $-0.4B | $-0.4B |